Sensitization of head and neck squamous cell carcinoma cells to Fas-mediated apoptosis by the inhibition of Bcl-X(L) expression.

[1]  H. Pehamberger,et al.  Bcl‐XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy , 2002, International journal of cancer.

[2]  S. Ugurel,et al.  Heterogenous susceptibility to CD95‐induced apoptosis in melanoma cells correlates with bcl‐2 and bcl‐x expression and is sensitive to modulation by interferon‐γ , 1999, International journal of cancer.

[3]  B. Monia,et al.  Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli , 1999, Oncogene.

[4]  E. Alnemri,et al.  Abrogation of Mitochondrial Cytochrome c Release and Caspase-3 Activation in Acquired Multidrug Resistance* , 1998, The Journal of Biological Chemistry.

[5]  S. Srinivasula,et al.  Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. , 1998, Molecular cell.

[6]  L. Fritz,et al.  Bcl-xL Functions Downstream of Caspase-8 to Inhibit Fas- and Tumor Necrosis Factor Receptor 1-induced Apoptosis of MCF7 Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[7]  P. Möller,et al.  Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. , 1998, Cancer research.

[8]  Brent R. Stockwell,et al.  An Induced Proximity Model for Caspase-8 Activation* , 1998, The Journal of Biological Chemistry.

[9]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[10]  R. Gottlieb,et al.  Bcl-2 and the Outer Mitochondrial Membrane in the Inactivation of Cytochrome c during Fas-mediated Apoptosis* , 1997, The Journal of Biological Chemistry.

[11]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[12]  M. Lavin,et al.  Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. , 1997, Cancer research.

[13]  K. Bhalla,et al.  Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. , 1997, Cancer research.

[14]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[15]  C. Thompson,et al.  Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Núñez,et al.  Interaction and Regulation of Subcellular Localization of CED-4 by CED-9 , 1997, Science.

[17]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[18]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[19]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[20]  M. Mandal,et al.  Bcl-2 Prevents CD95 (Fas/APO-1)-induced Degradation of Lamin B and Poly(ADP-ribose) Polymerase and Restores the NF-κB Signaling Pathway* , 1996, The Journal of Biological Chemistry.

[21]  F. Shanahan,et al.  The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand , 1996, The Journal of experimental medicine.

[22]  S. Korsmeyer,et al.  Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors* , 1996, The Journal of Biological Chemistry.

[23]  E. Podack,et al.  Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. , 1996, International immunology.

[24]  S. Nagata,et al.  Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.

[25]  A. Chinnaiyan,et al.  Molecular Ordering of the Cell Death Pathway , 1996, The Journal of Biological Chemistry.

[26]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[27]  L. Owen-Schaub,et al.  Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. , 1994, Cancer research.

[28]  Takashi Suda,et al.  Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.

[29]  K. Nishioka,et al.  Caspase-9 regulates cisplatin-induced apoptosis in human head and neck squamous cell carcinoma cells. , 2000, Cancer letters.

[30]  K. Koretz,et al.  Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[31]  J. Kerr,et al.  Patterns of cell death. , 1988, Methods and achievements in experimental pathology.